FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

719412001: Naloxegol oxalate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3316260018 Naloxegol oxalate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3316261019 Naloxegol oxalate en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Naloxegol oxalate Is a Naloxegol false Inferred relationship Existential restriction modifier
Naloxegol oxalate Has disposition Opioid receptor antagonist true Inferred relationship Existential restriction modifier
Naloxegol oxalate Has disposition Opioid receptor agonist false Inferred relationship Existential restriction modifier
Naloxegol oxalate Is modification of Naloxegol true Inferred relationship Existential restriction modifier
Naloxegol oxalate Is a Morphinan true Inferred relationship Existential restriction modifier
Naloxegol oxalate Is a Antidote true Inferred relationship Existential restriction modifier
Naloxegol oxalate Is a Substance with opioid receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely naloxegol (as naloxegol oxalate) 25 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Naloxegol oxalate Inferred relationship Existential restriction modifier 1
Product containing precisely naloxegol (as naloxegol oxalate) 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Naloxegol oxalate Inferred relationship Existential restriction modifier 1
Naloxegol 12.5mg tablets Has specific active ingredient True Naloxegol oxalate Inferred relationship Existential restriction modifier
Naloxegol 25mg tablets Has specific active ingredient True Naloxegol oxalate Inferred relationship Existential restriction modifier
Moventig 12.5mg tablets (AstraZeneca UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Naloxegol oxalate Inferred relationship Existential restriction modifier
Moventig 25mg tablets (AstraZeneca UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Naloxegol oxalate Inferred relationship Existential restriction modifier
Naloxegol 25mg tablets 30 tablet Has specific active ingredient True Naloxegol oxalate Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets 30 tablet Has specific active ingredient True Naloxegol oxalate Inferred relationship Existential restriction modifier
Moventig 12.5mg tablets (AstraZeneca UK Ltd) Has specific active ingredient True Naloxegol oxalate Inferred relationship Existential restriction modifier
Moventig 25mg tablets (AstraZeneca UK Ltd) Has specific active ingredient True Naloxegol oxalate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start